Through our Young Investigator awards, we combat the loss of promising scientists from the field by providing financial support to investigators early in their research careers and providing them with career development and mentoring opportunities. These grants are limited to truly transformational science designed to deliver innovative cancer treatments toward clinical trials and train the next generation of pediatric cancer researchers.

To learn more about applying for one of our grants, click here.

YOUNG INVESTIGATOR – ACTIVE PROJECTS

Jamie Anastas, PhD
Baylor College of Medicine
Focus: Pediatric High-Grade Glioma
Project title: Combinatorial targeting of HDACs and LSD1 to treat pediatric brain tumors 

Joanna Gell, MD
Connecticut Children’s
Focus: Intracranial Germ Cell Tumor (iGCT)
Project title: Development of a targeted compound for the germ cell tumor marker PRDM14 

Francesca Nazio, PhD
Ospedale Pediatrico Bambino Gesù

Focus: Medulloblastoma
Project title: Targeting autophagy to boost the immune response against medulloblastoma 

Estibaliz Lopez Rodrigo, MD
Memorial Sloan Kettering Cancer Center

Focus: Metastatic Osteosarcoma
Project title: Targeting macrophages in lung osteosarcomagenesis 

Dr. Kathryn Lemberg
Johns Hopkins University
Focus: Malignant Peripheral Nerve Sheath Tumor
Project Title: JHU395: A glutamine antagonist for malignant peripheral nerve sheath tumor

Mark Kohler, MD, PhD
University of Colorado Cancer Center
Focus: Acute Myeloid Leukemia (AML)
Project title:
Multi-antigen targeting CAR T cells for relapsed/refractory pediatric AML

Dr. Ranjith Menon Muraleedharan
Yale University School of Medicine
Focus: Diffuse Intrinsic Pontine Glioma
Project Title: Exploiting metabolic defects with NAMPT inhibitors in DIPG 

Adam Durbin, MD, PhD
St. Jude Children’s Research Hospital
Focus: Neuroblastoma
Project title: Novel agents targeting EP300-regulated transcription in neuroblastoma

Dr. Loretta Li
Ann & Robert H. Lurie Children’s Hospital of Chicago & Northwestern University
Focus: High-risk B-cell Acute Lymphoblastic Leukemia
Project Title:  JAK2 inhibition and degradation in B-cell acute lymphoblastic leukemia

Frequently Asked Questions

Pin It on Pinterest

Scroll to Top